-
Association between Polypharmacy and Cognitive Limitations among Adults with Depression in the United States
Mar 10, 2025, 14:00 PM -
Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments
Mar 10, 2025, 14:00 PM -
Association Between Initiation of ENDS and Cigarette Smoking Reduction: A Causal Time Zero Approach to the PATH Study
Mar 10, 2025, 14:00 PM -
Dual Inhibitor Identification for Mutated IDH1/2 To Reduce D-2-Hydroxyglutarate in Glioblastoma
Mar 10, 2025, 14:00 PM -
Exploring the Link Between Self-Efficacy and Medication Adherence: Psychometric Evaluation of the Traditional Chinese Beliefs About Medicines Questionnaire-Specific in Adults With Type 2 Diabetes
Mar 10, 2025, 14:00 PM -
A Framework for Evaluating the Economic and Operational Impact of Adopting the Sentimag®platform for Lesion Localization and Sentinel Lymph Node Biopsy in Women with Breast Cancer
Mar 10, 2025, 14:00 PM -
Navigating Uncertainty in Overall Survival Data: Insights from Positive Canadian HTAs on Lung Cancer Therapies
Mar 10, 2025, 14:00 PM -
Economic Feasibility of 'Pay One Price': An Analysis of Three Biosimilar Molecules with Different Prices and Indicated for Rheumatoid Arthritis in a Medium Size HMO
Mar 10, 2025, 14:00 PM -
Assessing the Impact of PD-L1 and BRAF Biomarkers on Long-Term Survivorship (LTS) Rates Among Treatment-Naive Advanced Melanoma Patients Receiving Immune Checkpoint Inhibitors (ICIs)
Mar 10, 2025, 14:00 PM -
The Role of Absolute Summaries in Detecting Intransitivity and Model Mis-Specification in Indirect Treatment Comparisons
Mar 10, 2025, 14:00 PM -
A Cost-Effectiveness Analysis of Diagnostic Testing in Alzheimer's Disease
Mar 10, 2025, 14:00 PM -
Predictive Models and Risk Scoring System Development for Assessing Survival in Uterine Cancer Patients With Type 2 Diabetes Mellitus: A Territory-Wide Cohort Study
Mar 10, 2025, 14:00 PM -
Hydroxyurea Use and Clinical Outcomes Among Adults with Severe Sickle Cell Disease: A retrospective Cohort Study using Electronic Health Record Data
Mar 10, 2025, 14:00 PM -
Target Aggregate Data Adjustment Method (TADA): A Solution for Performing Transportability Analysis with Only Aggregate-Level Data in the Target Population
Mar 10, 2025, 14:00 PM -
Real-World Utilization of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults
Mar 10, 2025, 14:00 PM -
Hypophosphatasia (HPP) Patient & Caregiver Disease Burden, Quality of Life & Treatment Experience: A Mixed Methods Study Concept
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Continuous Glucose Monitoring with Predictive Alarms for Type 1 Diabetes in Chile (T1D): Perspective of the Explicit Health Guarantees Regime.
Mar 10, 2025, 14:00 PM -
Impact of Treatment Response on Quality of Life and Health-Related Utility Values in Hepatitis: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Evaluation of the Impact of Fezolinetant vs Placebo on Indirect Costs Among Women With VMS Associated With Menopause
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Exagamglogene Autotemcel (Exa-cel) on Health Inequalities in Patients with Sickle Cell Disease in the United Kingdom and Canada
Mar 10, 2025, 14:00 PM
